Dollar Tree Inc. Stock Outperforms Competitors Despite Losses On The Day

Enzolytics Inc

Change company Symbol lookup

Select an option...

ENZC Enzolytics Inc

GREE Greenidge Generation Holdings Inc

MLM Martin Marietta Materials Inc

ERESW East Resources Acquisition Equity Warrant Exp 1st July 2027 *W EXP 07/01/2027

NRAC Noble Rock Acquisition Corp

DCGO DocGo Inc

VELOW Velocity Acquisition Equity Warrant Exp 24 Feb 2028 *W EXP 02/24/2028

MRC MRC Global Inc

BAC Bank of America Corp

BKR Baker Hughes Co

Company profile

Enzolytics, Inc. is a drug development biotechnology company. The Company is engaged in the commercialization of its proteins for the treatment of debilitating infectious diseases. The Company is focused in developing monoclonal antibody therapy and treating infectious diseases. It has anti-HIV therapeutics and a methodology for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The Company has clinically tested anti-HIV therapeutics. The Company has developed a cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus. The Company has also created human cell lines that produce human antibodies against other infectious diseases, including rabies, influenza, tetanus, and diphtheria. The Company is testing these antibodies to prepare them for use as therapies against these diseases.

Dollar Tree Inc. Stock Outperforms Competitors Despite Losses On The Day

4:30 pm ET January 12, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Dollar Tree Inc. (DLTR) slumped 0.15% to $136.90 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.28% to 4,726.35 and the Dow Jones Industrial Average rising 0.11% to 36,290.32. Dollar Tree Inc. closed $12.47 short of its 52-week high ($149.37), which the company reached on November 24th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Target Corp. (TGT) fell 1.35% to $224.47, Dollar General Corp. (DG) fell 0.02% to $228.60, and Wal-Mart de Mexico S.A.B. de C.V. ADR (WALMEX.MX) rose 0.71% to $35.70. Trading volume (3.2 M) remained 551,739 below its 50-day average volume of 3.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 12, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

January 12, 2022 16:30 ET (21:30 GMT)